calcium oxalate has been researched along with eicosapentaenoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H; Kotake, T; Nomura, K | 1 |
| Hesse, A; Jansen, B; Siener, R; Watzer, B | 1 |
| Rodgers, AL; Siener, R | 1 |
1 review(s) available for calcium oxalate and eicosapentaenoic acid
| Article | Year |
|---|---|
The Efficacy of Polyunsaturated Fatty Acids as Protectors against Calcium Oxalate Renal Stone Formation: A Review.
Topics: Calcium Oxalate; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-6; Fish Oils; Humans; Kidney Calculi | 2020 |
2 other study(ies) available for calcium oxalate and eicosapentaenoic acid
| Article | Year |
|---|---|
Effect of ethyl icosapentate on urinary calcium excretion in calcium oxalate stone formers.
Topics: Adult; Aged; Calcium; Calcium Oxalate; Eicosapentaenoic Acid; Female; Humans; Magnesium; Male; Middle Aged; Prostaglandins; Urea; Uric Acid; Urinary Calculi | 1995 |
Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone formation.
Topics: Administration, Oral; Calcium Oxalate; Cohort Studies; Dietary Supplements; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Follow-Up Studies; Humans; Kidney Calculi; Male; Reference Values; Risk Factors; Treatment Outcome; Urinalysis; Urinary Calculi | 2011 |